NCT01426373 - Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area | Biotech Hunter

Enrollment

165

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Moderate or Severe Submental Fullness

Interventions

DRUG

Deoxycholic acid injection

Formulated as an injectable solution containing deoxycholic acid at a concentration of 10 mg/mL.

Trial Locations (18)

10016

Roy Geronemus, MD, New York

10028

Macrene Alexiades-Armenakas, New York

19067

Richard Fried, Yardley

27517

Sue Ellen Cox, Chapel Hill

33401

Palm Beach Cosmetic, West Palm Beach

34209

Susan Weinkle, Bradenton

37215

Michael Gold, Nashville

48088

Grekin Skin Institute, Warren

60611

Steven Dayan, Chicago

70124

Lupo Center for Aesthetic and General Dermatology, New Orleans

75093

Jeffrey Adelglass, Plano

77056

Suzanne Bruce, Houston

90212

Mark Rubin, Beverly Hills

90404

Ava Shamban, Santa Monica

Steven Teitelbaum, Santa Monica

92121

Mitchel Goldman, La Jolla

92675

Jeffrey Klein, San Juan Capistrano

08844

David Goldberg, MD, Hillsborough